The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodents

Anesthesia and Analgesia

Volumn 104, Issue 1, 2007, Pages 174-179

  Byford, Alan J ^a   Anderson, Alison ^a   Jones, Philip S ^a   Palin, Ronald ^a   Houghton, Andrea K ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [1 [3 (5 METHOXY 2 METHYLPHENOXY 4 METHYLPENTYL)]PIPERIDINYL] 1,3 DIHYDRO 2H BENZIMIDAZOL 2 ONE; 8 ACENAPHTEN 1 YL 1 PHENYL 1,3,8 TRIAZASPIRO[4,5]DECAN 4 ONE; FORMALDEHYDE; NALOXONE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; OPIOID LIKE RECEPTOR 1; ORG 26383; PROPOFOL; RO 65 6570; UNCLASSIFIED DRUG; 8 ACENAPHTHEN 1 YL 1 PHENYL 1,3,8 TRIAZASPIRO(4.5)DECAN 4 ONE; 8-ACENAPHTHEN-1-YL-1-PHENYL-1,3,8-TRIAZASPIRO(4.5)DECAN-4-ONE; IMIDAZOLE DERIVATIVE; NOCICEPTIN RECEPTOR; SPIRO COMPOUND;

ANESTHESIA INDUCTION; ANIMAL BEHAVIOR; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; HYPNOSIS; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SLEEP TIME; STATISTICAL SIGNIFICANCE; ANIMAL; ANIMAL MODEL; DRUG POTENTIATION; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; WISTAR RAT;

ANIMALS; ELECTROENCEPHALOGRAPHY; HUMANS; IMIDAZOLES; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED ICR; MODELS, ANIMAL; NALOXONE; RATS; RATS, WISTAR; RECEPTORS, OPIOID; SPIRO COMPOUNDS;

EID: 33847638802     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000250403.88649.51     Document Type: Article

References (20)

1. Mollereau C, Parmentier M, Mailleux P, et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 1994;341:33-8.
2. Bunzow JR, Saez C, Mortrud M, et al. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ, or κ receptor type. FEBS Lett 1994;347:284-8.
3. Meunier JC, Mollereau C, Toll L, et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995;377:532-5.
4. Reinscheid RK, Nothacker HP, Bourson A, et al. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995;270:792-4.
5. Mogil JS, Pasternak GW. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 2001;53:381-415.
6. Mørk H, Hommel K, Uddman R, et al. Does nociceptin play a role in pain disorders in man? Peptides 2002;23:1581-7.
7. Yu L-C, Lu J-T, Huang Y-H, et al. Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats. Brain Res 2002;945:88-96.
8. Bertorelli R, Bastia E, Citterio F, et al. Lack of the nociceptin receptor does not affect acute or chronic nociceptin in mice. Peptides 2002;23:1589-96.
9. Zaveri N. Peptide and nonpeptide ligands for the nociceptin/ orphanin FQ receptor ORL1: research tools and potential therapeutic agents. Life Sci 2003;73:663-78.
10. Higgins GA, Grottick AJ, Ballard TM, et al. Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function. Neuropharmacology 2001;41:97-107.
11. Palin R, Barn DR, Clark JK, et al. Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists. Bioorg Med Chem Lett 2005;15:589-93.
12. Vijn PC, Sneyd JR. IV anaesthesia and EEG burst suppression in rats: bolus injections and closed-loop infusions. Br J Anaesth 1998;81:415-21.
13. Yaksh TL, Ozaki G, McCumber D, et al. An automated flinch detecting system for use in the formalin nociceptive bioassay. J Appl Physiol 2001;90:2386-402.
14. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brainstem stimulation in rats and cats. Pain 1977;4:161-74.
15. Cesura A, Adam G. 8-substituted-1,3,8-triazaspiro[4.5]decan-4-on derivatives. Eur. Pat. 0856514. August 5, 1998.
16. Derbyshire AJ, Rempel B, Forbes A, Lambert EF. The effects of anesthetics on action potentials in the cerebral cortex of the cat. Am J Physiology 1936;116:577-96.
17. Clark DL, Rosner BS. Neurophysiologic effects of general anesthetics (1973). I. The electroencephalogram and sensory evoked responses in man. Anesthesiology 1973;38:564-82.
18. Hartikainen K, Rorarius M, Makela K, et al. Propofol and isoflurane induced EEG burst suppression patterns in rabbits. Acta Anaesth Scand 1995;39:814-18.
19. Rampil IJ, Weiskopf RB, Brown JG, et al. I653 and isoflurane produce similar dose-related changes in the electroencephalogram of pigs. Anesthesiology 1988;69:298-302.
20. Korkmaz S, Wahlstrom G. The EEG burst suppression threshold test for the determination of CNS sensitivity to intravenous anesthetics in rats. Brain Res Brain Res Protoc 1997;1: 378-84.